Showing results (741-750 of 5,684) with videos related to

Sort By:
Pageof 569
The Oncologist|July 1, 2025
Efficacy and safety of anamorelin in patients with metastatic urothelial carcinoma receiving systemic chemotherapy: a randomized controlled studyKunihiro Odagiri, Yoshihisa Mimura, Taku Naiki, et al.
The Oncologist|July 1, 2025
Risk assessment in a Chinese cohort of 96 318 females undergoing opportunistic cervical cancer screeningJing Zhao, Wenhan Li, Zehua Wang, et al.
The Oncologist|June 30, 2025
Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breastSeda Sali, Mursel Sali, Burcu Caner, et al.
The Oncologist|June 24, 2025
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcomaVinayak Venkataraman, Hannah R Abrams, David S Shulman, et al.
The Oncologist|January 6, 2026
Induction chemoimmunotherapy followed by concurrent radiotherapy in patients with locally advanced esophageal cancer: a single-arm phase 2 trialHui Chen, Zeyuan Liu, Wang Zheng, et al.
The Oncologist|December 24, 2025
Baseline geriatric 8 (G8) screening tool predicts overall survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitorsChristopher H Rhee, Subir Goyal, Yuan Liu, et al.
The Oncologist|December 22, 2025
Chemotherapy improves survival for patients with lymph node-negative invasive papillary breast cancer with tumors ≥2 cm: a SEER population-based studyYi-Zi Zheng, Zhuo-Zhao Zhan, Ting-Ting Wu, et al.
The Oncologist|December 22, 2025
Clinical and radiomics parameter prognostication in metastatic uveal melanoma patients treated with hepatic arterial infusion chemotherapyTanja Gromke, Juliane Durand, Tamara T Mueller, et al.
The Oncologist|December 15, 2025
Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusionFiras Akrout, Henri Bogumil, Mohamed Dehmani Yedeas, et al.
The Oncologist|December 15, 2025
Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapyManuel Modiano, Shanta Chawla, Jeffrey L Vacirca, et al.
Pageof 569